PetVivo Holdings Inc
Zach Swanson serves as the Laboratory Manufacturing & Operations Manager at PetVivo Holdings Inc since August 2021, focusing on the development of scalable manufacturing procedures for Petvivo's Spryng with Osteocushion Technology, aimed at treating osteoarthritis in companion animals. Previously, from July 2014 to November 2021, Zach managed islet manufacturing and R&D at the University of Minnesota, overseeing the isolation purification and quality control of pancreatic islets for transplantation studies. Additionally, Zach gained experience as a nationally registered Emergency Medical Technician with Lake City Ambulance Service and other EMS providers from November 2013 to August 2017, delivering pre-hospital medical care. Earlier academic roles included peer tutoring and lab assistance at Winona State University. Zach holds a Master’s Degree in Biological and Biomedical Sciences from the University of Minnesota and a Bachelor’s Degree in Biochemistry and Cell and Molecular Biology from Winona State University.
PetVivo Holdings Inc
PetVivo, Inc is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics. PetVivo believes that it can leverage the investments in the human biomaterials and medical device industries to commercialize therapeutics to pets in a capital and time efficient way. PetVivo's strategy is to in-license proprietary products from human medical device companies specifically for use in pets. PetVivo, Inc, Gel-Del Technologies, Inc. and CosmetaLife a Corporation are all wholly-owned subsidiaries of PetVivo Holdings, Inc.